Standout Papers
- MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy (2017)
- The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2 (2019)
Immediate Impact
2 from Science/Nature 74 standout
Citing Papers
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
2025 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Olga Burdaeva being referenced
An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer
2019
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Olga Burdaeva | 1563 | 1630 | 73 | 621 | 27 | 2.0k | |
| Yuan Liu | 1141 | 1308 | 41 | 746 | 41 | 1.7k | |
| Han Koh | 2178 | 1883 | 28 | 836 | 25 | 2.7k | |
| Meena Okera | 1488 | 1678 | 21 | 617 | 32 | 2.0k | |
| C. Giorgetti | 2077 | 2144 | 42 | 874 | 33 | 2.9k | |
| S. Phan | 1604 | 1340 | 76 | 513 | 43 | 2.4k | |
| Nawel Bourayou | 1797 | 2026 | 23 | 723 | 23 | 2.3k | |
| Yuqiu Jiang | 1542 | 1357 | 122 | 829 | 26 | 2.3k | |
| Kathy Puyana Theall | 1828 | 2049 | 19 | 787 | 26 | 2.3k | |
| Dylan Conklin | 1185 | 1064 | 43 | 394 | 31 | 1.8k | |
| Eric Gauthier | 2337 | 2492 | 25 | 889 | 41 | 3.0k |
All Works
Loading papers...